Spring Valley Acquisition Corp. II (SVII) 10-Q14 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2024	Nov. 13, 2024
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-41529
Entity Registrant Name	SPRING VALLEY ACQUISITION CORP. II
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1579063
Entity Address, Address Line One	2100 McKinney Ave., Suite 1675
Entity Address, City or Town	Dallas
Entity Address State Or Province	TX
Entity Address, Postal Zip Code	75201
City Area Code	214
Local Phone Number	308-5230
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001843477
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant
Document and Entity Information
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant
Trading Symbol	SVIIU
Security Exchange Name	NASDAQ
Class A ordinary shares
Document and Entity Information
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	SVII
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		9,880,095
Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share
Document and Entity Information
Title of 12(b) Security	Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share
Trading Symbol	SVIIR
Security Exchange Name	NASDAQ
Redeemable public warrants included as part of the units; each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Document and Entity Information
Title of 12(b) Security	Redeemable public warrants included as part of the units; each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	SVIIW
Security Exchange Name	NASDAQ
Class B ordinary shares
Document and Entity Information
Entity Common Stock, Shares Outstanding		1

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 727,713	$ 1,240,671
Prepaid expenses	21,272	80,895
Total current assets	748,985	1,321,566
Non-current assets:
Investments held in Trust Account	166,325,780	249,254,022
Total non-current assets	166,325,780	249,254,022
Total Assets	167,074,765	250,575,588
Current liabilities:
Accounts payable	76,450	82,462
Accrued expenses	106,000	$ 91,600
Extension promissory notes - related party	$ 1,350,000
Other Liability, Current, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Total current liabilities	$ 1,532,450	$ 174,062
Deferred underwriting commissions	2,817,500	8,050,000
Total Liabilities	4,349,950	8,224,062
Commitments and Contingencies
Shareholders' Deficit:
Preference shares, $0.0001 par value 1,000,000 shares authorized none issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
Accumulated deficit	(3,601,732)	(6,903,263)
Total shareholders' deficit	(3,600,965)	(6,902,496)
Total Liabilities and Shareholders' Deficit	167,074,765	250,575,588
Class A ordinary shares subject to possible redemption
Current liabilities:
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; 14,637,766 and 23,000,000 shares subject to possible redemption at $11.36 and $10.84 per share as of September 30, 2024 and December 31, 2023, respectively	166,325,780	249,254,022
Class A ordinary shares subject not to possible redemption
Shareholders' Deficit:
Ordinary shares	$ 767
Class B ordinary shares
Shareholders' Deficit:
Ordinary shares		$ 767

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A ordinary shares
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized (in shares)	300,000,000	300,000,000
Class A ordinary shares subject to possible redemption
Ordinary shares subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption, shares authorized (in shares)	300,000,000	300,000,000
Ordinary shares subject to possible redemption, shares outstanding (in shares)	14,637,766	23,000,000
Ordinary shares subject to possible redemption, redemption price per share	$ 11.36	$ 10.84
Class A ordinary shares subject not to possible redemption
Common shares, shares issued (in shares)	7,666,666	0
Common shares, shares outstanding (in shares)	7,666,666	0
Class B ordinary shares
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized (in shares)	30,000,000	30,000,000
Common shares, shares issued (in shares)	1	7,666,667
Common shares, shares outstanding (in shares)	1	7,666,667

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
General and administrative expenses	$ 184,576	$ 211,375	$ 616,555	$ 598,253
Loss from operations	(184,576)	(211,375)	(616,555)	(598,253)
Other Income:
Interest income on operating account	9,504	12,799	35,586	13,530
Income from investments held in Trust Account	2,131,750	3,163,146	6,448,228	8,543,476
Total other income	2,141,254	3,175,945	6,483,814	8,557,006
Net income	$ 1,956,678	$ 2,964,570	$ 5,867,259	$ 7,958,753
Class A ordinary shares subject to possible redemption
Other Income:
Basic weighted average shares outstanding (in shares)	14,637,766	23,000,000	14,942,957	23,000,000
Diluted weighted average shares outstanding (in shares)	14,637,766	23,000,000	14,942,957	23,000,000
Basic net income per share (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Diluted net income per share (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Class A ordinary shares subject not to possible redemption
Other Income:
Basic weighted average shares outstanding (in shares)	7,666,666		6,967,153
Diluted weighted average shares outstanding (in shares)	7,666,666		6,967,153
Basic net income per share (in dollars per share)	$ 0.09		$ 0.26
Diluted net income per share (in dollars per share)	$ 0.09		$ 0.26
Class B ordinary shares
Other Income:
Basic weighted average shares outstanding (in shares)	1	7,666,667	699,514	7,666,667
Diluted weighted average shares outstanding (in shares)	1	7,666,667	699,514	7,666,667
Basic net income per share (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Diluted net income per share (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Class A ordinary shares Common Stock	Class A ordinary shares subject to possible redemption	Class B Ordinary Shares Common Stock	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2022			$ 767	$ (6,058,698)	$ (6,057,931)
Balance at the beginning (in shares) at Dec. 31, 2022			7,666,667
Increase (Decrease) in Stockholders' Equity
Accretion of Class A ordinary shares to redemption amount subject to possible redemption				(2,519,340)	(2,519,340)
Net Income				2,326,083	2,326,083
Balance at the end at Mar. 31, 2023			$ 767	(6,251,955)	(6,251,188)
Balance at the end (in shares) at Mar. 31, 2023			7,666,667
Balance at the beginning at Dec. 31, 2022			$ 767	(6,058,698)	(6,057,931)
Balance at the beginning (in shares) at Dec. 31, 2022			7,666,667
Increase (Decrease) in Stockholders' Equity
Net Income					7,958,753
Balance at the end at Sep. 30, 2023			$ 767	(6,643,421)	(6,642,654)
Balance at the end (in shares) at Sep. 30, 2023			7,666,667
Balance at the beginning at Mar. 31, 2023			$ 767	(6,251,955)	(6,251,188)
Balance at the beginning (in shares) at Mar. 31, 2023			7,666,667
Increase (Decrease) in Stockholders' Equity
Accretion of Class A ordinary shares to redemption amount subject to possible redemption				(2,860,990)	(2,860,990)
Net Income				2,668,100	2,668,100
Balance at the end at Jun. 30, 2023			$ 767	(6,444,845)	(6,444,078)
Balance at the end (in shares) at Jun. 30, 2023			7,666,667
Increase (Decrease) in Stockholders' Equity
Accretion of Class A ordinary shares to redemption amount subject to possible redemption				(3,163,146)	(3,163,146)
Net Income				2,964,570	2,964,570
Balance at the end at Sep. 30, 2023			$ 767	(6,643,421)	(6,642,654)
Balance at the end (in shares) at Sep. 30, 2023			7,666,667
Balance at the beginning at Dec. 31, 2023			$ 767	(6,903,263)	(6,902,496)
Balance at the beginning (in shares) at Dec. 31, 2023			7,666,667
Increase (Decrease) in Stockholders' Equity
Accretion of Class A ordinary shares to redemption amount subject to possible redemption		$ (2,214,919)		(2,664,919)	(2,664,919)
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption	$ 767		$ (767)
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	7,666,666		(7,666,666)
Net Income				1,979,098	1,979,098
Balance at the end at Mar. 31, 2024	$ 767			(7,589,084)	(7,588,317)
Balance at the end (in shares) at Mar. 31, 2024	7,666,666		1
Balance at the beginning at Dec. 31, 2023			$ 767	(6,903,263)	(6,902,496)
Balance at the beginning (in shares) at Dec. 31, 2023			7,666,667
Increase (Decrease) in Stockholders' Equity
Net Income					5,867,259
Balance at the end at Sep. 30, 2024	$ 767			(3,601,732)	(3,600,965)
Balance at the end (in shares) at Sep. 30, 2024	7,666,666		1
Balance at the beginning at Mar. 31, 2024	$ 767			(7,589,084)	(7,588,317)
Balance at the beginning (in shares) at Mar. 31, 2024	7,666,666		1
Increase (Decrease) in Stockholders' Equity
Accretion of Class A ordinary shares to redemption amount subject to possible redemption		(2,101,560)		(2,551,559)	(2,551,559)
Net Income				1,931,483	1,931,483
Balance at the end at Jun. 30, 2024	$ 767			(8,209,160)	(8,208,393)
Balance at the end (in shares) at Jun. 30, 2024	7,666,666		1
Increase (Decrease) in Stockholders' Equity
Deferred Underwriting Commissions Waived		3,996,825		5,232,500	5,232,500
Accretion of Class A ordinary shares to redemption amount subject to possible redemption		$ (1,865,075)		(2,581,750)	(2,581,750)
Net Income				1,956,678	1,956,678
Balance at the end at Sep. 30, 2024	$ 767			$ (3,601,732)	$ (3,600,965)
Balance at the end (in shares) at Sep. 30, 2024	7,666,666		1

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		9 Months Ended
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net income			$ 5,867,259	$ 7,958,753
Adjustments to reconcile net income to net cash used in operating activities:
Income from investments held in the Trust Account	$ (2,131,750)	$ (3,163,146)	(6,448,228)	(8,543,476)
Changes in operating assets and liabilities:
Prepaid expenses			59,623	235,066
Accounts payable			(6,012)	(24,896)
Accrued expenses			14,400	52,148
Net cash used in operating activities			(512,958)	(322,405)
Cash Flows from Investing Activities:
Cash deposited in the trust account for the extension			(1,350,000)
Cash withdrawn from trust account for redemption of Class A ordinary shares			90,726,471
Net cash provided by investing activities			89,376,471
Cash Flows from Financing Activities:
Proceeds from promissory note to related party- extension			1,350,000
Redemption of Class A ordinary shares			(90,726,471)
Net cash used in financing activities			(89,376,471)
Net change in cash			(512,958)	(322,405)
Cash - beginning of the period			1,240,671	1,731,726
Cash - end of the period	$ 727,713	$ 1,409,321	$ 727,713	$ 1,409,321

Description of Organization, Bu

Description of Organization, Business Operations and Liquidity	9 Months Ended
	Sep. 30, 2024
Description of Organization, Business Operations and Liquidity
Description of Organization, Business Operations and Liquidity	Note 1 — Description of Organization, Business Operations and Liquidity Spring Valley Acquisition Corp. II (the “Company”) is a blank check company incorporated in the Cayman Islands on January 19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of September 30, 2024, the Company had not commenced any operations. All activities for the period from January 19, 2021 (inception) through September 30, 2024, relate to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and, since the closing of the Initial Public Offering, the search for and efforts towards completing an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating interest income on investments held in the Trust Account (as defined below). The Company’s Sponsor is Spring Valley Acquisition Sponsor II, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 12, 2022. On October 17, 2022, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including the issuance of 3,000,000 Units as a result of the underwriter’s full exercise of their over-allotment option, at $10.00 per Unit, generating gross proceeds of approximately $230.0 million, and incurring offering costs of approximately $13.4 million, of which approximately $8.1 million was for deferred underwriting commissions (see Note 5). Each Unit consists of one Class A ordinary share, one right to receive one-tenth one Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (the “Private Placement”) of 13,350,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $13.4 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, approximately $235.8 million ($10.25 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement, was placed in a trust account (the “Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting discounts held in the Trust Account and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the Target (as defined below) or otherwise acquires a controlling interest in the Target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the Company’s issued and outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro-rata portion of the amount then held in the Trust Account ($10.25 per Public Share initially, $11.36 per Public Share as of September 30, 2024). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). The Public Shares were recorded at a redemption value and classified as temporary equity upon consummation of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the majority of the shares voted are in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agree to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders will not be entitled to redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agree to vote their Founder Shares, and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Amended and Restated Memorandum and Articles of Association, as amended, provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 36 months from the closing of the Initial Public Offering, or October 17, 2025 (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. Initially, the Company had 15 months from the closing of the initial public offering or until January 17, 2024, to consummate an initial Business Combination. However, on January 11, 2024, the Company filed with the Registrar of Companies of the Cayman Islands an amendment to the Amended and Restated Memorandum and Articles of Association to: (i) to change the date by which the Company must consummate a Business Combination to October 17, 2025 or such earlier date as is determined by the Company’s board of directors (the “Board”), in its sole discretion, to be in the best interests of the Company (the “Extension Amendment”); (ii) to remove the limitation that the company shall not redeem Class A ordinary shares included as part of the units sold in its Initial Public Offering prior to the consummation of a Business Combination that would cause the Company’s net tangible assets to be less than $5,000,001 following such repurchases, (the “Redemption Limitation Amendment”); and (iii) to provide for the right of a holder of Class B ordinary shares, par value $0.0001 per share, to convert such shares into shares of the Company’s Class A ordinary shares on a one-for-one basis prior to initial Business Combination (the “Conversion Amendment” and, together with the Extension Amendment and the Redemption Limitation, the “Charter Amendments”). On January 10, 2024, the Company held an extraordinary general meeting of shareholders in lieu of an annual general meeting (the “Shareholder Meeting”) at which their shareholders approved: (a) an amendment to our Amended and Restated Memorandum and Articles of Association: (i) to change the date by which the Company must consummate a business combination to October 17, 2025 or such earlier date as is determined by the Board, in its sole discretion, to be in the best interests of the Company (the “Extension Amendment”); (ii) to remove the limitation that the company shall not redeem Class A ordinary shares included as part of the units sold in its initial public offering prior to the consummation of a business combination that would cause the Company’s net tangible assets to be less than $5,000,001 following such repurchases, (the “Redemption Limitation Amendment”); and (iii) to provide for the right of a holder of Class B ordinary shares, par value $0.0001 per share, to convert such shares into shares of the Company’s Class A ordinary shares on a one-for-one basis prior to initial business combination (the “Conversion Amendment”), and (b) the appointment of Richard Thompson and Sharon Youngblood as Class I directors to each serve on the Board for a three Additionally, shareholders holding 8,362,234 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.85 per share, for an aggregate redemption amount of $90,726,471. In connection with the approval of the Conversion Amendment, on January 25, 2024, the Sponsor voluntarily elected to convert 7,546,666 of its Class B ordinary shares to Class A ordinary shares, and the independent directors of the Company voluntarily elected to convert an aggregate of 120,000 Class B ordinary shares to Class A ordinary shares, in each case, on a one-for-one basis in accordance with the articles (such conversions collectively, the “Founder Share Conversion,” and the Class A ordinary shares issued upon such conversion, the “Converted Class A Shares”). After giving effect to the Founder Share Conversion, one Sponsor-held Class B ordinary share remains issued and outstanding. Following such redemptions and the conversion of Class B ordinary shares, 22,304,432 Class A ordinary shares remain outstanding, including 14,637,766 publicly held Class A ordinary shares. The Sponsor and the independent directors waived any right to receive funds from the Trust Account established by the Company in connection with its Initial Public Offering that was consummated on October 17, 2022, with respect to any Converted Class A Shares, and no additional funds were deposited into the Trust Account in respect of any such shares. The Converted Class A Shares will remain subject to the existing transfer restrictions on the Class B ordinary shares following such conversions. In connection with the approval of the Extension Amendment, the Sponsor issued an unsecured promissory note to the Company pursuant to which the Sponsor has agreed to make monthly deposits directly to the Company’s Trust Account of $150,000 per month (each deposit is a “Contribution”). The maximum aggregate amount of all Contributions under the promissory note will not exceed $3,150,000. The Contributions are paid monthly (or a pro-rata portion thereof if less than a full month), beginning on January 11, 2024, and thereafter on the fifteenth day of each subsequent month (or if such fifteenth day is not a business day, on the business day immediately preceding such fifteenth day) until the earlier of (i) the consummation of a Business Combination, and (ii) the end of the Combination Period. The promissory note is non-interest bearing and is payable upon the consummation of the initial Business Combination and if the Business Combination is not consummated, the date of the termination, dissolution, or winding up of the Company as determined in the sole discretion of the Board. On October 2, 2024, the Board determined that in order to make the Company a more attractive partner to sponsors of special purpose acquisition companies seeking to take over the management and affairs of special purpose acquisition companies, following the extraordinary general meeting of shareholders held on November 13, 2024, the Sponsor and any successor to the obligations of the Sponsor are no longer be required to make monthly deposits to the Trust Account of $0.02 for each outstanding Class A ordinary share, up to a maximum of $150,000 per month. The Company received an aggregate amount of Contributions from the Sponsor totaling $1,350,000 for the period from January 11, 2024, through September 30, 2024, under the promissory note. In connection with the vote to approve the Amendment (as defined below) at the extraordinary general meeting held on November 13, 2024, holders of 12,424,337 Class A ordinary shares exercised their right to redeem their Class A ordinary shares for cash at a redemption price of approximately $11.43 per share, for an aggregate redemption amount of approximately $142,010,171. As a result, approximately $25,135,029 remains in the Trust Account and 9,880,095 Class A ordinary shares remain outstanding. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.25 per Public Share or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of September 30, 2024, the Company had approximately $0.7 million in cash held outside of the Trust Account and a working capital deficit of approximately $0.8 million after considering the extension promissory note of $1.3 The Company’s liquidity needs to date were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and loan from the Sponsor of approximately $269,000 under the Note (as defined in Note 4) and the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. The Company repaid the Note in full on October 18, 2022, and the facility is no longer available. In addition, in order to finance the transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team, or any of their affiliates may provide the Company with Working Capital Loans (as defined in Note 4) as may be required (of which up to $1.5 million may be converted at the lender’s option into warrants). As of September 30, 2024, and December 31, 2023, there was no Working Capital Loan outstanding. Based on the current operating plan, management believes that the Company will not have sufficient working capital to meet its working capital needs through the earlier of consummation of an initial Business Combination or mandatory liquidation date. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management plans to complete the initial Business Combination prior to the mandatory liquidation date and expects to receive financing from the Sponsor or the affiliates of the Sponsor to meet its obligations through the time of liquidation or the completion of the initial Business Combination. There is no financing that is currently committed and no assurance that the Company’s plans to consummate the initial Business Combination will be successful within the Combination Period (by October 17, 2025). The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. On October 7, 2023, the State of Israel was attacked by Hamas, a Palestinian militant group designated as a Foreign Terrorist organization by the U.S. Department of State. As a result of this attack, the State of Israel commenced a military operation against Hamas which is supported by various nations including the United States. The impact of the above actions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. The Company’s ability to consummate an initial business combination, or the operations of a target business with which the Company ultimately consummates an initial business combination, may be materially and adversely affected by these military actions and related sanctions. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations, or ability to consummate an initial business combination are not yet determinable. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2024
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with U.S. GAAP for interim financial information and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024, or any future period. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of operating cash accounts and investments held in the Trust Account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2024, and December 31, 2023. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. In contrast, when the investments held in Trust Account are comprised of money market funds, these are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2024, and December 31, 2023, the assets held in the Trust Account were in mutual funds. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company evaluates its equity-linked financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the unaudited condensed statements of operations each reporting period. The classification of derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company accounted for the Rights and warrants to be issued in connection with the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that the Rights and warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the instruments continue to be classified in equity. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants and Rights were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Class A Ordinary Shares Subject to Possible Redemption As discussed in Note 1, all of the 23,000,000 Class A ordinary shares sold as parts of the Units in the Initial Public Offering contain a redemption feature. In accordance with the ASC 480-10-S99-3A, “Classification and Measurement of Redeemable Securities”, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. The Company classified all of the Class A ordinary shares as redeemable. Immediately upon the closing of the Initial Public Offering, the Company recognized a charge against additional paid-in capital (to the extent available) and accumulated deficit for the difference between the initial carrying value of the Class A ordinary shares and the redemption value. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in retained earnings, or in the absence of retained earnings, in additional paid-in capital. As discussed in Note 1, the Company held the Shareholder Meeting to, among other things, extend the time the Company has to complete a business combination from January 17, 2024, to October 17, 2025. In connection with the Shareholder Meeting, the Company’s shareholders holding 8,362,234 Class A ordinary shares exercised their right to redeem such shares for a pro-rata portion of the funds in the Trust Account, and as a result, $90,726,471 (approximately $10.85 per share) was redeemed from the Trust Account to pay such holders. Following the redemptions, the Company had 14,637,766 Class A ordinary shares (subject to possible redemption) outstanding. As described in Note 1, the Sponsor issued an unsecured promissory note to the Company pursuant to which the Sponsor has agreed to make monthly deposits directly to the Company’s Trust Account of $150,000 per month. The maximum aggregate amount under the promissory note (“note”) will not exceed $3,150,000. As of September 30, 2024, $1,350,000 has been borrowed against the note and deposited into the trust account. The contributions received are reflected as accretion to redemption value in the table below. As of September 30, 2024, the amounts of Class A ordinary shares reflected on the unaudited condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption - December 31, 2023 $ 249,254,022 Less: Redemption (90,726,471) Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,214,919 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - March 31, 2024 (unaudited) $ 161,192,470 Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,101,560 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - June 30, 2024 (unaudited) $ 163,744,030 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption 1,865,075 Plus: Waiver of deferred underwriting fees 3,996,825 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption: (3,100,750) Plus: Waiver of deferred underwriting fees 5,232,500 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780 Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has three classes of shares, which are referred to as (i) Class A ordinary shares subject to possible redemption (consisting of 14,637,766 publicly held Class A ordinary shares); (ii) Class A ordinary shares not subject to redemption (consisting of 7,666,666 Class A ordinary shares held by the Sponsor and the Company’s independent directors); and (iii) Class B ordinary shares. Income and losses are shared pro rata between the three classes of shares. Any of the Company’s Class B ordinary shares that are converted into Class A ordinary shares on a one-for-one basis, herein after referred to as the “Converted Class A shares.” Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the periods. Remeasurement associated with the redeemable Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value. Therefore, the net income per ordinary share calculation allocates the income pro rata between Class A ordinary shares subject to possible redemption, Class A ordinary shares not subject to possible redemption, and Class B ordinary shares. The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an aggregate of 24,850,000 Class A ordinary shares and the effect of the Rights to receive 2,300,000 Class A ordinary shares in the calculation of diluted income per ordinary share since the exercise of the warrants is contingent upon the occurrence of future events. The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the nine months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 3,877,738 $ 1,807,995 $ 181,526 $ 5,969,065 $ 1,989,688 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,942,957 6,967,153 699,514 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.26 $ 0.26 $ 0.26 $ 0.26 $ 0.26 For the three months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 1,284,112 $ 672,566 $ 0.09 $ 2,223,427 $ 741,143 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,637,766 7,666,666 1 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.09 $ 0.10 $ 0.10 Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2024 and December 31, 2023. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company has not been subject to income tax examinations by major taxing authorities since its inception. There is currently no taxation imposed on income by the government of the Cayman Islands (“Cayman”). In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements In October 2021, the FASB issued Accounting Standard Update (“ASU”) No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”. The ASU requires companies to apply the definition of a performance obligation under ASC 606, “Revenue from Contracts with Customers”, to recognize and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired, and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted this guidance on January 1, 2023, using a prospective method, and the adoption did not have any impact on the unaudited condensed financial statements. In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires additional disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The Company adopted the provisions of this guidance with effect from January 1, 2023. The adoption did not have a material impact on the Company’s condensed financial statements. In June 2022, the FASB issued ASU No. 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions,” to clarify the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The amendments in ASU 2022-03 clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. In addition, the amendments in ASU 2022-03 require certain additional disclosures related to investments in equity securities subject to contractual sale restrictions. The amendments in ASU 2022-03 will become effective for the Company as of the beginning of the Company’s 2025 fiscal year. Early adoption is permitted. As of September 30, 2024, the Company does not hold any investments in equity securities, therefore the Company does not currently expect that this guidance will have a material impact upon the Company’s financial position and results of operations. In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The ASU updates reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. This update is effective beginning with the Company’s 2024 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its condensed financial statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic ASC 740) Income Taxes.” The ASU improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in ASU 2023-09 will become effective for the Company as of the beginning of the Company’s 2026 fiscal year. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company does not expect that this guidance will have a material impact on the Company’s financial position and results of operations. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable.

Initial Public Offering

Initial Public Offering	9 Months Ended
Initial Public Offering	Sep. 30, 2024
Initial Public Offering
Initial Public Offering	Note 3 — Initial Public Offering On October 17, 2022, the Company consummated its Initial Public Offering of 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriters’ full exercise of their over-allotment option, at $10.00 per Unit, generating gross proceeds of approximately $230.0 million, and incurring offering costs of approximately $13.4 million, of which approximately $8.1 million was for deferred underwriting commissions. Each Unit consists of one share of Class A ordinary shares, one one

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2024
Related Party Transactions
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On January 26, 2021, the Sponsor purchased 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), to cover certain expenses on the Company’s behalf for an aggregate purchase price of $25,000. On March 18, 2022, the Company effectuated a share capitalization with respect to its Class B ordinary shares of 1,916,667 shares thereof, resulting in an aggregate of 7,666,667 Class B ordinary shares outstanding. The Sponsor agreed to forfeit up to an aggregate of 1,000,000 Founder Shares to the extent that the option to purchase additional Units was not exercised in full by the underwriters or is reduced so that the Founder Shares would represent 25% of the Company’s issued and outstanding shares after the Initial Public Offering. On October 17, 2022, the underwriters consummated the exercise in full of the over-allotment; thus, these 1,000,000 Founder Shares were no longer subject to forfeiture. The initial shareholders, and the executive officers and directors of the Company, agreed not to transfer, assign, or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property, excluding ordinary shares subject to forfeiture. The Founder Shares are subject to performance and market condition vesting terms. The Sponsor agreed that upon and subject to the completion of the initial Business Combination, 25% of the Founder Shares then held by the Sponsor shall be considered to be newly unvested shares, which will vest only if the closing price of the Company’s Class A ordinary shares on the Nasdaq equals or exceeds $12.50 for any 20 trading days within a 30 trading day period commencing at least 120 days after the closing of the initial Business Combination but before the fifth anniversary. The Sponsor agreed, subject to exceptions, not to transfer any unvested Founder Shares prior to the date such securities become vested. Founder Shares, if any, that remain unvested at the fifth anniversary of the closing of the initial Business Combination will be forfeited, subject to certain exceptions. Notwithstanding the foregoing, and subject to the satisfaction of the other transfer restrictions on the Founder Shares described herein, the Sponsor may be able to transfer up to 80% of its Founder Shares even if it is required to forfeit all of its unvested Founder Shares and even if the trading price of Class A ordinary shares declines materially. The issuance of Founder Shares to the Sponsor is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founder Shares were granted subject to a performance condition and a market condition. Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of October 17, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation will be recognized at the date a Business Combination is considered probable (i.e., upon completion of a Business Combination) in an amount equal to the number of Founder Shares that ultimately vest multiplied by the grant date fair value per share, which considers the market condition in the valuation, less the amount initially received for the purchase of the Founder Shares. In February 2021, the Sponsor transferred 40,000 Class B ordinary shares to each of the Company’s directors. The sale of the Founder Shares is in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of these 120,000 shares granted to the Company’s directors was $452,000 or $3.77 per share. The Company estimates grant date fair value using Monte Carlo Simulation, considering the probability and timing of IPO completion, business combination completion, and an appropriate discount for lack of marketability, all Level 3 Inputs under ASC 820. The following assumptions were used for the determination of grant date fair value for the shares transferred to directors. Risk-free interest rate 0.30 % Expected term (in years) 3.96 The Founder Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As discussed in Note 1, on January 25, 2024, the Sponsor voluntarily elected to convert 7,546,666 of its Class B ordinary shares to Class A ordinary shares, and the independent directors of the Company voluntarily elected to convert an aggregate of 120,000 Class B ordinary shares to Class A ordinary shares, in each case, on a one-for-one basis and Company issued an aggregate of 7,666,666 shares of Class A ordinary shares not subject to redemption. The Converted Class A Shares will remain subject to the existing transfer restrictions on the Class B ordinary shares following such conversions. As of September 30, 2024, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founder Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founder Shares. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 13,350,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $13.4 million. Each Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per ordinary share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. The purchasers of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign, or sell any of their Private Placement Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination. Related Party Loans Promissory Note to Sponsor The Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note, dated January 26, 2021, and was later amended and restated on January 28, 2022, and subsequently amended and restated a second time on September 26, 2022 (the “Note”). The Note was non-interest bearing, unsecured, and due upon the closing of the Initial Public Offering. The Company fully repaid the Note on October 18, 2022. Upon consummation of the Initial Public Offering, the Note was no longer available to the Company. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2024 and December 31, 2023, no amounts have been drawn on the Working Capital Loans. Extension Loans As described in Note 1, in connection with the extension on January 10, 2024, Sponsor issued an unsecured promissory note to the Company pursuant to which Sponsor has agreed to make monthly deposits directly to the Company’s Trust Account of $150,000 per month. The maximum aggregate amount under the promissory note will not exceed $3,150,000. The deposits are paid monthly (or a pro-rata portion thereof if less than a full month), began on January 11, 2024, and thereafter on the fifteenth day of each subsequent month (or if such fifteenth day is not a business day, on the business day immediately preceding such fifteenth day) until the earlier of (i) the consummation of a Business Combination, and (ii) the end of the Combination Period. The promissory note is non-interest bearing and is payable upon the consummation of the initial Business Combination and if the Business Combination is not consummated, the date of the termination, dissolution, or winding up of the Company as determined in the sole discretion of the Company’s board of directors. On October 2, 2024, the Board determined that in order to make the Company a more attractive partner to sponsors of special purpose acquisition companies seeking to take over the management and affairs of special purpose acquisition companies, following the extraordinary general meeting of shareholders held on November 13, 2024, the Sponsor and any successor to the obligations of the Sponsor are no longer be required to make monthly deposits to the Trust Account of $0.02 for each outstanding Class A ordinary share, up to a maximum of $150,000 per month. As of September 30, 2024, $1,350,000 has been borrowed against the promissory note and deposited in the Trust Account. Administrative Services Agreement On October 12, 2022, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor an amount of $10,000 per month for office space, secretarial and administrative support services provided to members of the management team through the earlier of consummation of the initial Business Combination and the liquidation. The Company incurred $30,000 and $90,000 in such fees included as general and administrative expenses on the accompanying condensed statement of operations for the three and nine months ended September 30, 2024, and 2023. The Company had unpaid fees of $90,000 as of September 30, 2024, and $30,000 as of December 31, 2023. In addition, the Sponsor, officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account. For the three months ended September 30, 2024, and 2023, there were no expenses to be reimbursed.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies
Commitments and Contingencies	Note 5 — Commitments and Contingencies Shareholder and Registration Rights The holders of Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement to be signed upon the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $4.6 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.35 per Unit, or approximately $8.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On September 30, 2024, one of the underwriters in the Initial Public Offering, Citigroup Global Markets Inc., elected to waive its rights to receive its portion of the deferred underwriting commission. This portion accounted for approximately $5.2 million of the total deferred underwriting commission liability of $8.0 million. On October 18, 2024, one of the underwriters in the Initial Public Offering, Guggenheim Securities, elected to waive its rights to receive its portion of the deferred underwriting commission amounting to $2.8 million. Therefore, as of October 18, 2024, the total amount of deferred underwriting commission of $8.0 million was waived. Deferred Legal Fees The Company engaged a legal counsel firm for legal advisory services, and the legal counsel agreed to defer a portion of their fees (“Deferred Legal Fees”). The deferred fee will become payable solely in the event that the Company completes a Business Combination. As of September 30, 2024, and December 31, 2023, the Company had Deferred Legal Fees of approximately $1,320,000 and $1,054,000 in connection with such services, respectively. The Company will recognize an expense for these services when the performance trigger is considered probable.

Shareholders' Deficit

Shareholders' Deficit	9 Months Ended
Shareholders' Deficit	Sep. 30, 2024
Shareholders' Deficit
Shareholders' Deficit	Note 6 — Shareholders’ Deficit Preference Shares — Class A Ordinary Shares On January 25, 2024, the Company issued an aggregate of 7,666,666 shares of Class A ordinary shares, upon conversion of an equal number of shares of Class B ordinary shares. The 7,666,666 shares of Class A ordinary shares issued in connection with the Conversion are subject to the same restrictions as applied to the shares of Class B ordinary shares before the conversion, including, among others, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination as described in the prospectus for the Company’s initial public offering. After giving effect to the Founder Share Conversion, prior to the redemptions in connection with Amendment, the total number of shares of Class A ordinary shares that are issued and outstanding consists of 22,304,432 Class A ordinary shares (consisting of 14,637,766 publicly-held Class A ordinary shares, 7,546,666 Converted Class A shares held by Spring Valley Acquisition Sponsor II, LLC, and 120,000 Converted Class A shares not subject to redemption held by the registrant’s independent directors). Class B Ordinary Shares — Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right to vote on the election of the Company’s directors prior to the initial Business Combination. As described in Note 1, the Sponsor voluntarily elected to convert 7,546,666 of its Class B ordinary shares to Class A ordinary shares, and the independent directors of the Company voluntarily elected to convert an aggregate of 120,000 Class B ordinary shares to Class A ordinary shares, in each case, on a one-for-one basis. The Sponsor and the independent directors waived any right to receive funds from the Trust Account established by the Company in connection with its Initial Public Offering that was consummated on October 17, 2022, with respect to any Converted Class A shares, and no additional funds were deposited into the Trust Account in respect of any such Converted Class A shares. The Converted Class A Shares will remain subject to the existing transfer restrictions on the Class B ordinary shares following such conversions. As of September 30, 2024, and December 31, 2023, there were 1 and 7,666,667 Class B ordinary shares issued and outstanding, respectively. Rights — one Warrants — The exercise price of each Warrant is $11.50 per share, subject to adjustment as described herein. In addition, if the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price. The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; and ● if, and only if the last reported sale price of Class A ordinary shares for any 20 trading days within a 30 - trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders equals or exceeds $18.00 per share (as adjusted). The Company will not redeem the Public Warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30 day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each Public Warrant being exercised. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable, or saleable until 30 days after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable and will be exercisable at the election of the holder on a “cashless basis.” In no event, the Company will be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2024
Fair Value Measurements
Fair Value Measurements	Note 7 — Fair Value Measurements The following tables present information about the Company’s financial assets that are measured at fair value on a recurring basis as of September 30, 2024, and December 31, 2023, by level within the fair value hierarchy: September 30, 2024 Quoted Prices in Active Significant Other Significant Other Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Cash and Investments held in Trust Account - U.S. Treasury Securities $ 166,325,780 $ — $ — December 31, 2023 Quoted Prices in Active Significant Other Significant Other Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Cash and Investments held in Trust Account - U.S. Treasury Securities $ 249,254,022 $ — $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There was no transfer between levels during the three and nine months ended September 30, 2024 and 2023.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Events
Subsequent Events	Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements, other than the following. On October 10, 2024, the Company filed a definitive proxy statement for an extraordinary general meeting to seek approval of the “Extension Amendment Proposal.” This proposal would amend the Company’s memorandum and articles of association, allowing the board discretion to liquidate the Company before the current deadline of October 17, 2025, if it serves the shareholders’ best interests. The board has since rescheduled the extraordinary general meeting to November 13, 2024, and filed an 8-K on November 12, 2024, to announce this updated date. Deferred Underwriting Commissions On October 18, 2024, Guggenheim Securities decided to waive its rights to receive its portion of the deferred underwriting commission amounting to $2.8 million. Therefore, as of October 18, 2024, the total amount of deferred underwriting commissions was waived. Articles Amendment On November 13, 2024, the Company held an extraordinary general meeting of shareholders (the “Meeting”) to approve an amendment to the Company’s Amended and Restated Memorandum and Articles of Association to amend the date by which the Company must consummate an initial business combination to 36 months from the closing of the initial public offering, or such earlier date as is determined by the Company’s board of directors, in its sole discretion, to be in the best interests of the Company (the “Amendment”). In connection with the vote to approve the Amendment, holders of 12,724,337 redemption amount of approximately $142,010,171. As a result, approximately $25,135,029 remains in the Trust Account and 9,880,095 Class A ordinary shares remain outstanding. Non-Redemption Agreements On October 24, 2024, October 25, 2024, November 8, 2024, November 11, 2024 and November 12, 2024, in connection with the Meeting, the Company and the Company’s Sponsor, entered into non-redemption agreements with several unaffiliated third parties, pursuant to which such third parties agreed not to redeem (or to validly rescind any redemption requests on) an aggregate of 2,075,000 Class A ordinary shares, par value $0.0001 of the Company in connection with the Extension Amendment Proposal. In exchange for the foregoing commitments not to redeem such Class A ordinary shares of the Company, the Sponsor agreed to transfer or cause to be issued for no consideration an aggregate of 691,666 Founder Shares of the Company on the occurrence of an initial business combination. Extension Contributions On October 2, 2024, the Board determined that in order to make the Company a more attractive partner to sponsors of special purpose acquisition companies seeking to take over the management and affairs of special purpose acquisition companies, following the Meeting, the Sponsor and any successor to the obligations of the Sponsor are no longer be required to make monthly deposits to the Trust Account of $0.02 for each outstanding Class A ordinary share, up to a maximum of $150,000 per month.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($)	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 1,956,678	$ 1,931,483	$ 1,979,098	$ 2,964,570	$ 2,668,100	$ 2,326,083	$ 5,867,259	$ 7,958,753

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2024
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with U.S. GAAP for interim financial information and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024, or any future period.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of operating cash accounts and investments held in the Trust Account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2024, and December 31, 2023.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. In contrast, when the investments held in Trust Account are comprised of money market funds, these are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2024, and December 31, 2023, the assets held in the Trust Account were in mutual funds.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its equity-linked financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the unaudited condensed statements of operations each reporting period. The classification of derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company accounted for the Rights and warrants to be issued in connection with the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that the Rights and warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the instruments continue to be classified in equity.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants and Rights were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption As discussed in Note 1, all of the 23,000,000 Class A ordinary shares sold as parts of the Units in the Initial Public Offering contain a redemption feature. In accordance with the ASC 480-10-S99-3A, “Classification and Measurement of Redeemable Securities”, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. The Company classified all of the Class A ordinary shares as redeemable. Immediately upon the closing of the Initial Public Offering, the Company recognized a charge against additional paid-in capital (to the extent available) and accumulated deficit for the difference between the initial carrying value of the Class A ordinary shares and the redemption value. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in retained earnings, or in the absence of retained earnings, in additional paid-in capital. As discussed in Note 1, the Company held the Shareholder Meeting to, among other things, extend the time the Company has to complete a business combination from January 17, 2024, to October 17, 2025. In connection with the Shareholder Meeting, the Company’s shareholders holding 8,362,234 Class A ordinary shares exercised their right to redeem such shares for a pro-rata portion of the funds in the Trust Account, and as a result, $90,726,471 (approximately $10.85 per share) was redeemed from the Trust Account to pay such holders. Following the redemptions, the Company had 14,637,766 Class A ordinary shares (subject to possible redemption) outstanding. As described in Note 1, the Sponsor issued an unsecured promissory note to the Company pursuant to which the Sponsor has agreed to make monthly deposits directly to the Company’s Trust Account of $150,000 per month. The maximum aggregate amount under the promissory note (“note”) will not exceed $3,150,000. As of September 30, 2024, $1,350,000 has been borrowed against the note and deposited into the trust account. The contributions received are reflected as accretion to redemption value in the table below. As of September 30, 2024, the amounts of Class A ordinary shares reflected on the unaudited condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption - December 31, 2023 $ 249,254,022 Less: Redemption (90,726,471) Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,214,919 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - March 31, 2024 (unaudited) $ 161,192,470 Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,101,560 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - June 30, 2024 (unaudited) $ 163,744,030 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption 1,865,075 Plus: Waiver of deferred underwriting fees 3,996,825 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption: (3,100,750) Plus: Waiver of deferred underwriting fees 5,232,500 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780
Net Income per Ordinary Share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has three classes of shares, which are referred to as (i) Class A ordinary shares subject to possible redemption (consisting of 14,637,766 publicly held Class A ordinary shares); (ii) Class A ordinary shares not subject to redemption (consisting of 7,666,666 Class A ordinary shares held by the Sponsor and the Company’s independent directors); and (iii) Class B ordinary shares. Income and losses are shared pro rata between the three classes of shares. Any of the Company’s Class B ordinary shares that are converted into Class A ordinary shares on a one-for-one basis, herein after referred to as the “Converted Class A shares.” Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the periods. Remeasurement associated with the redeemable Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value. Therefore, the net income per ordinary share calculation allocates the income pro rata between Class A ordinary shares subject to possible redemption, Class A ordinary shares not subject to possible redemption, and Class B ordinary shares. The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an aggregate of 24,850,000 Class A ordinary shares and the effect of the Rights to receive 2,300,000 Class A ordinary shares in the calculation of diluted income per ordinary share since the exercise of the warrants is contingent upon the occurrence of future events. The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the nine months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 3,877,738 $ 1,807,995 $ 181,526 $ 5,969,065 $ 1,989,688 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,942,957 6,967,153 699,514 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.26 $ 0.26 $ 0.26 $ 0.26 $ 0.26 For the three months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 1,284,112 $ 672,566 $ 0.09 $ 2,223,427 $ 741,143 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,637,766 7,666,666 1 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.09 $ 0.10 $ 0.10
Income Taxes	Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2024 and December 31, 2023. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company has not been subject to income tax examinations by major taxing authorities since its inception. There is currently no taxation imposed on income by the government of the Cayman Islands (“Cayman”). In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In October 2021, the FASB issued Accounting Standard Update (“ASU”) No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”. The ASU requires companies to apply the definition of a performance obligation under ASC 606, “Revenue from Contracts with Customers”, to recognize and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired, and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted this guidance on January 1, 2023, using a prospective method, and the adoption did not have any impact on the unaudited condensed financial statements. In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires additional disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The Company adopted the provisions of this guidance with effect from January 1, 2023. The adoption did not have a material impact on the Company’s condensed financial statements. In June 2022, the FASB issued ASU No. 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions,” to clarify the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The amendments in ASU 2022-03 clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. In addition, the amendments in ASU 2022-03 require certain additional disclosures related to investments in equity securities subject to contractual sale restrictions. The amendments in ASU 2022-03 will become effective for the Company as of the beginning of the Company’s 2025 fiscal year. Early adoption is permitted. As of September 30, 2024, the Company does not hold any investments in equity securities, therefore the Company does not currently expect that this guidance will have a material impact upon the Company’s financial position and results of operations. In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The ASU updates reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. This update is effective beginning with the Company’s 2024 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its condensed financial statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic ASC 740) Income Taxes.” The ASU improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in ASU 2023-09 will become effective for the Company as of the beginning of the Company’s 2026 fiscal year. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company does not expect that this guidance will have a material impact on the Company’s financial position and results of operations. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2024
Summary of Significant Accounting Policies
Schedule of class A ordinary shares reflected on the unaudited condensed balance sheets are reconciled	Class A ordinary shares subject to possible redemption - December 31, 2023 $ 249,254,022 Less: Redemption (90,726,471) Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,214,919 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - March 31, 2024 (unaudited) $ 161,192,470 Plus: Adjustment for accretion of Class A ordinary shares subject to possible redemption 2,101,560 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - June 30, 2024 (unaudited) $ 163,744,030 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption 1,865,075 Plus: Waiver of deferred underwriting fees 3,996,825 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption: (3,100,750) Plus: Waiver of deferred underwriting fees 5,232,500 Adjustment for Contributions under promissory note 450,000 Class A ordinary shares subject to possible redemption - September 30, 2024 (unaudited) $ 166,325,780
Schedule of calculation of basic and diluted net income per ordinary share	The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the nine months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 3,877,738 $ 1,807,995 $ 181,526 $ 5,969,065 $ 1,989,688 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,942,957 6,967,153 699,514 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.26 $ 0.26 $ 0.26 $ 0.26 $ 0.26 For the three months ended September 30, 2024 2023 Class A Class A Class A (subject to (not subject to (subject to redemption) redemption) Class B redemption) Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 1,284,112 $ 672,566 $ 0.09 $ 2,223,427 $ 741,143 Denominator: Basic and diluted weighted average ordinary shares outstanding 14,637,766 7,666,666 1 23,000,000 7,666,667 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.09 $ 0.10 $ 0.10

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
Related Party Transactions (Tables)	Sep. 30, 2024
Related Party Transactions
Schedule of assumptions were used for the determination of grant date fair value for the shares transferred to directors	Risk-free interest rate 0.30 % Expected term (in years) 3.96

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2024
Fair Value Measurements
Schedule of company's financial assets that are measured at fair value on a recurring basis	September 30, 2024 Quoted Prices in Active Significant Other Significant Other Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Cash and Investments held in Trust Account - U.S. Treasury Securities $ 166,325,780 $ — $ — December 31, 2023 Quoted Prices in Active Significant Other Significant Other Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Cash and Investments held in Trust Account - U.S. Treasury Securities $ 249,254,022 $ — $ —

Description of Organization, _2

Description of Organization, Business Operations and Liquidity (Details)						3 Months Ended	9 Months Ended
	Nov. 13, 2024 USD ($) $ / shares shares	Oct. 02, 2024 USD ($) $ / shares	Jan. 25, 2024 USD ($) shares	Jan. 10, 2024 USD ($) $ / shares shares	Oct. 17, 2022 USD ($) item $ / shares shares	Mar. 31, 2024 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Nov. 12, 2024 shares	Nov. 11, 2024 shares	Nov. 08, 2024 shares	Oct. 25, 2024 shares	Oct. 24, 2024 shares	Jan. 11, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares shares	Mar. 18, 2022 shares
Initial Public Offering
Purchase price, per unit \| $ / shares					$ 10.25		$ 11.36
Gross proceeds \| $					$ 235,800,000
Number of shares issued per right							0.10
One or more initial business combinations having an aggregate fair market value \| item					1
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account					80%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination					50%
Redemption limit percentage without prior consent					15
Obligation to redeem public shares if entity does not complete a business combination (as a percent)					100%
Period for consummation of business combination					15 months
Extended period for business combination					3 years
Additional fund deposited into trust account \| $			$ 0
Net intangible assets \| $				$ 5,000,001									$ 5,000,001
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)			7,666,666
Cash held in the Trust Account \| $							$ 727,713							$ 1,240,671
Working Capital \| $							800,000
Extension promissory notes - related party \| $							1,350,000
Consideration received from sponsor \| $							25,000
Loan amount converted into warrants \| $							1,500,000
Outstanding working capital loans \| $							$ 0							$ 0
Class A ordinary shares
Initial Public Offering
Common shares, par value (in dollars per share) \| $ / shares							$ 0.0001							$ 0.0001
Conversion ratio			1	1			1						1
Ordinary shares, shares issued (in shares)			22,304,432
Ordinary shares, shares outstanding (in shares)			22,304,432
Class A ordinary shares \| Common Stock
Initial Public Offering
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)						7,666,666
Class A ordinary shares subject to possible redemption
Initial Public Offering
Ordinary shares subject to possible redemption, redemption price per share \| $ / shares				$ 10.85			$ 11.36							$ 10.84
Redemption of shares				8,362,234
Aggregate redemption amount \| $				$ 90,726,471		$ (90,726,471)
Ordinary shares subject to possible redemption, shares outstanding (in shares)			14,637,766				14,637,766							23,000,000
Class B Ordinary Shares
Initial Public Offering
Common shares, par value (in dollars per share) \| $ / shares				$ 0.0001			$ 0.0001						$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)							1							7,666,667
Ordinary shares, shares outstanding (in shares)							1							7,666,667	7,666,667
Class B Ordinary Shares \| Common Stock
Initial Public Offering
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)						(7,666,666)
Subsequent events
Initial Public Offering
Trust Account \| $	$ 25,135,029
Subsequent events \| Class A ordinary shares
Initial Public Offering
Ordinary shares, shares outstanding (in shares)	9,880,095
Subsequent events \| Class A ordinary shares \| Common Stock
Initial Public Offering
Ordinary shares exercised	12,424,337
Ordinary shares for cash at a redemption price \| $ / shares	$ 11.43
Aggregate redemption amount \| $	$ 142,010,171
Subsequent events \| Class A ordinary shares subject to possible redemption
Initial Public Offering
Ordinary shares subject to possible redemption, shares outstanding (in shares)								2,075,000	2,075,000	2,075,000	2,075,000	2,075,000
Related Party
Initial Public Offering
Note payable - related party \| $							$ 269,000
Sponsor
Initial Public Offering
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)			7,546,666
Sponsor \| Class A ordinary shares
Initial Public Offering
Ordinary shares, shares outstanding (in shares)			7,546,666
Sponsor \| Class B Ordinary Shares
Initial Public Offering
Ordinary shares, shares issued (in shares)			1
Ordinary shares, shares outstanding (in shares)			1
Sponsor \| Unsecured promissory note
Initial Public Offering
Notes payable \| $				$ 1,350,000
Monthly contribution to trust account \| $				150,000			150,000
Maximum aggregate amount \| $				$ 3,150,000			$ 3,150,000
Sponsor \| Unsecured promissory note \| Subsequent events
Initial Public Offering
Monthly contribution to trust account \| $		$ 150,000
Sponsor \| Unsecured promissory note \| Subsequent events \| Class A ordinary shares
Initial Public Offering
Monthly contribution to trust accounts per shares \| $ / shares		$ 0.02
Director
Initial Public Offering
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)			120,000
Director \| Class A ordinary shares
Initial Public Offering
Ordinary shares, shares outstanding (in shares)			120,000
Director \| Class B Ordinary Shares
Initial Public Offering
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)			120,000
Initial Public Offering
Initial Public Offering
Sale of Units, net of underwriting discounts (in shares)					23,000,000
Purchase price, per unit \| $ / shares					$ 10
Gross proceeds \| $					$ 230,000,000
Offering costs \| $					13,400,000
Deferred underwriting commissions \| $					$ 8,100,000
Number of shares issued per unit					1
Number of shares issued per right					0.10
Number of warrants in a unit					0.5
Period for consummation of business combination					36 months
Public share price (per share) \| $ / shares					$ 10.25
Private Placement
Initial Public Offering
Sale of private placement warrants (in shares)					13,350,000
Price of warrant \| $ / shares					$ 1
Proceeds from sale of private placement warrants \| $					$ 13,400,000
Over-allotment option
Initial Public Offering
Sale of Units, net of underwriting discounts (in shares)					3,000,000
Purchase price, per unit \| $ / shares					$ 10

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)		3 Months Ended	9 Months Ended
Summary of Significant Accounting Policies (Details)	Jan. 10, 2024 USD ($) $ / shares shares	Mar. 31, 2024 USD ($)	Sep. 30, 2024 USD ($) $ / shares shares	Jan. 25, 2024 shares	Jan. 11, 2024	Dec. 31, 2023 USD ($) $ / shares shares	Mar. 18, 2022 shares
Summary of Significant Accounting Policies
Cash equivalents \| $			$ 0			$ 0
Promissory note, borrowed amount \| $			1,350,000
Unrecognized tax benefits \| $			0			0
Unrecognized tax benefits accrued for interest and penalties \| $			$ 0			$ 0
Rights
Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share			2,300,000
Public Warrants and Private Placement Warrants
Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share			24,850,000
Class A ordinary shares
Summary of Significant Accounting Policies
Common shares, shares outstanding (in shares)				22,304,432
Conversion ratio	1		1	1	1
Class B Ordinary Shares
Summary of Significant Accounting Policies
Common shares, shares outstanding (in shares)			1			7,666,667	7,666,667
Class A ordinary shares subject to possible redemption
Summary of Significant Accounting Policies
Ordinary shares subject to possible redemption, shares outstanding (in shares)			14,637,766	14,637,766		23,000,000
Redemption of shares	8,362,234
Aggregate redemption amount \| $	$ 90,726,471	$ (90,726,471)
Redemption price \| $ / shares	$ 10.85		$ 11.36			$ 10.84

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of Class A ordinary shares (Details) - USD ($)			3 Months Ended
	Sep. 30, 2024	Jan. 10, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Summary of Significant Accounting Policies
Adjustment for accretion of Class A ordinary shares subject to possible redemption			$ 2,581,750	$ 2,551,559	$ 2,664,919	$ 3,163,146	$ 2,860,990	$ 2,519,340
Waiver of deferred underwriting fees	$ 5,200,000		5,232,500
Class A ordinary shares subject to possible redemption
Summary of Significant Accounting Policies
Class A ordinary shares subject to possible redemption			163,744,030	161,192,470	249,254,022
Redemption		$ 90,726,471			(90,726,471)
Adjustment for accretion of Class A ordinary shares subject to possible redemption	(3,100,750)		1,865,075	2,101,560	2,214,919
Adjustment for Contributions under promissory note	450,000		450,000	450,000	450,000
Waiver of deferred underwriting fees	5,232,500		3,996,825
Class A ordinary shares subject to possible redemption	$ 166,325,780		$ 166,325,780	$ 163,744,030	$ 161,192,470

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Basic and diluted net income (loss) per ordinary share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Class A ordinary shares subject not to possible redemption
Summary of Significant Accounting Policies
Allocation of net income	$ 672,566		$ 1,807,995
Weighted average ordinary shares outstanding - basic (in shares)	7,666,666		6,967,153
Weighted average ordinary shares outstanding - diluted (in shares)	7,666,666		6,967,153
Net income per ordinary share - basic (in dollars per share)	$ 0.09		$ 0.26
Net income per ordinary share - diluted (in dollars per share)	$ 0.09		$ 0.26
Class A ordinary shares subject to possible redemption
Summary of Significant Accounting Policies
Allocation of net income	$ 1,284,112	$ 2,223,427	$ 3,877,738	$ 5,969,065
Weighted average ordinary shares outstanding - basic (in shares)	14,637,766	23,000,000	14,942,957	23,000,000
Weighted average ordinary shares outstanding - diluted (in shares)	14,637,766	23,000,000	14,942,957	23,000,000
Net income per ordinary share - basic (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Net income per ordinary share - diluted (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Class B Ordinary Shares
Summary of Significant Accounting Policies
Allocation of net income	$ 0.09	$ 741,143	$ 181,526	$ 1,989,688
Weighted average ordinary shares outstanding - basic (in shares)	1	7,666,667	699,514	7,666,667
Weighted average ordinary shares outstanding - diluted (in shares)	1	7,666,667	699,514	7,666,667
Net income per ordinary share - basic (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26
Net income per ordinary share - diluted (in dollars per share)	$ 0.09	$ 0.10	$ 0.26	$ 0.26

Initial Public Offering - (Deta

Initial Public Offering - (Details) - USD ($) $ / shares in Units, $ in Millions		9 Months Ended
	Oct. 17, 2022	Sep. 30, 2024
Initial Public Offering
Purchase price, per unit	$ 10.25	$ 11.36
Number of shares issued per right		0.10
Initial Public Offering
Initial Public Offering
Sale of Units, net of underwriting discounts (in shares)	23,000,000
Purchase price, per unit	$ 10
Proceeds from issuance of Class B common stock to Sponsor	$ 230
Offering costs	13.4
Deferred underwriting fees	$ 8.1
Number of shares issued per unit	1
Number of warrants in a unit	0.5
Number of shares issued per right	0.10
Initial Public Offering \| Public Warrants
Initial Public Offering
Number of warrants in a unit	0.5
Number of shares issuable per warrant	1
Initial Public Offering \| Public Warrants \| Class A ordinary shares
Initial Public Offering
Exercise price of warrants	$ 11.50
Over-allotment option
Initial Public Offering
Sale of Units, net of underwriting discounts (in shares)	3,000,000
Purchase price, per unit	$ 10

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)					1 Months Ended	9 Months Ended
	Jan. 25, 2024	Oct. 17, 2022	Mar. 18, 2022	Jan. 26, 2021	Feb. 28, 2021	Sep. 30, 2024	Jan. 11, 2024	Jan. 10, 2024	Dec. 31, 2023
Related Party Transactions
Consideration received from sponsor						$ 25,000
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	7,666,666
Over-allotment option
Related Party Transactions
Issuance of Class B ordinary shares to Sponsor (shares)		3,000,000
Class B ordinary shares
Related Party Transactions
Common shares, par value (in dollars per share)						$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, shares outstanding (in shares)			7,666,667			1			7,666,667
Sponsor
Related Party Transactions
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	7,546,666
Recognized stock based compensation expense						$ 0
Sponsor \| Class B ordinary shares
Related Party Transactions
Common shares, shares outstanding (in shares)	1
Percentage of shares allowed for transfer						80%
Director
Related Party Transactions
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	120,000
Director \| Class B ordinary shares
Related Party Transactions
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	120,000
Founder shares \| Class B ordinary shares
Related Party Transactions
Shares capitalized for future			1,916,667
Shares subject to forfeiture			1,000,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			25%
Restrictions on transfer period of time after business combination completion						1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)						$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination						20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination						30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences						120 days
Founder shares \| Class B ordinary shares \| Over-allotment option
Related Party Transactions
Number of shares no longer subject to forfeiture		1,000,000
Founder shares \| Sponsor \| Class B ordinary shares
Related Party Transactions
Issuance of Class B ordinary shares to Sponsor (shares)				5,750,000	40,000
Common shares, par value (in dollars per share)				$ 0.0001
Consideration received from sponsor				$ 25,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders						25%
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)						$ 12.50
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination						20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination						30 days
Shares granted						120,000
Share granted value						$ 452,000
Amount granted per share						$ 3.77
Risk-free interest rate						0.30%
Expected term (in years)						3 years 11 months 15 days

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)						3 Months Ended	9 Months Ended
	Oct. 02, 2024	Jan. 25, 2024	Jan. 10, 2024	Oct. 17, 2022	Oct. 12, 2022	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Related Party Transactions
Promissory note, borrowed amount							$ 1,350,000
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)		7,666,666
Loan amount converted into warrants							1,500,000
Outstanding working capital loans						$ 0	0	$ 0
Additional fund deposited into trust account		$ 0
Sponsor
Related Party Transactions
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)		7,546,666
Private Placement Warrants
Related Party Transactions
Sale of private placement warrants (in shares)				13,350,000
Price of warrant				$ 1
Proceeds from sale of private placement warrants				$ 13,400,000
Number of shares issuable per warrant				1
Exercise price of warrants				$ 11.50
Promissory Note with Related Party
Related Party Transactions
Maximum borrowing capacity of related party promissory note						$ 300,000	$ 300,000
Related Party Loans \| Working capital loans warrant
Related Party Transactions
Price of warrant						$ 1	$ 1
Loan amount converted into warrants							$ 1,500,000
Unsecured promissory note \| Sponsor
Related Party Transactions
Monthly contribution to trust account			$ 150,000				150,000
Maximum aggregate amount			$ 3,150,000			$ 3,150,000	3,150,000
Promissory note, borrowed amount							1,350,000
Unsecured promissory note \| Sponsor \| Subsequent events
Related Party Transactions
Monthly contribution to trust account	$ 150,000
Unsecured promissory note \| Sponsor \| Class A ordinary shares \| Subsequent events
Related Party Transactions
Monthly contribution to trust accounts per shares	$ 0.02
Administrative Services Agreement
Related Party Transactions
Expenses per month					$ 10,000
Expenses incurred						30,000	90,000
Unpaid fees						$ 90,000	$ 90,000	$ 30,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)			3 Months Ended	9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Oct. 18, 2024	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Commitments and Contingencies
Underwriting cash discount per unit				$ 0.20
Aggregate underwriter cash discount				$ 4,600,000
Deferred Fee Per Unit		$ 0.35	$ 0.35	$ 0.35
Aggregate deferred underwriting fee payable				$ 8,100,000
Waiver of deferred underwriting fees		$ 5,200,000	$ 5,232,500
Deferred Underwriting Commissions				8,000,000
Deferred legal fees		$ 1,320,000	$ 1,320,000	$ 1,320,000	$ 1,054,000
Subsequent events
Commitments and Contingencies
Waiver of deferred underwriting fees	$ 8,000,000
Deferred Underwriting Commissions	$ 2,800,000

Shareholders' Deficit- Preferen

Shareholders' Deficit- Preference Shares (Details) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Shareholders' Deficit
Preferred shares, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued (in shares)	0	0
Preferred shares, shares outstanding (in shares)	0	0

Shareholders' Deficit - Ordinar

Shareholders' Deficit - Ordinary Shares (Details)		9 Months Ended
Shareholders' Deficit - Ordinary Shares (Details)	Jan. 25, 2024 USD ($) shares	Sep. 30, 2024 $ / shares shares	Jan. 11, 2024 $ / shares	Jan. 10, 2024 $ / shares	Dec. 31, 2023 $ / shares shares	Mar. 18, 2022 shares
Shareholders' Deficit
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	7,666,666
Number of rights outstanding		2,300,000			2,300,000
Number of shares issued per right		0.10
Number of shares issuable per right, if company will not be survivor upon completion of business combination		1
Fractional shares issued upon conversion of rights		0
Additional fund deposited into trust account \| $	$ 0
Sponsor
Shareholders' Deficit
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	7,546,666
Director
Shareholders' Deficit
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	120,000
Class A ordinary shares
Shareholders' Deficit
Ordinary shares, shares authorized (in shares)		300,000,000			300,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares		$ 0.0001			$ 0.0001
Ordinary shares, shares issued (in shares)	22,304,432
Ordinary shares, shares outstanding (in shares)	22,304,432
Conversion ratio	1	1	1	1
Class A ordinary shares \| Sponsor
Shareholders' Deficit
Ordinary shares, shares outstanding (in shares)	7,546,666
Class A ordinary shares \| Director
Shareholders' Deficit
Ordinary shares, shares outstanding (in shares)	120,000
Class A ordinary shares subject to possible redemption
Shareholders' Deficit
Ordinary shares subject to possible redemption, shares issued (in shares)		14,637,766			23,000,000
Ordinary shares subject to possible redemption, shares outstanding (in shares)	14,637,766	14,637,766			23,000,000
Class B ordinary shares
Shareholders' Deficit
Ordinary shares, shares authorized (in shares)		30,000,000			30,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)		1			7,666,667
Ordinary shares, shares outstanding (in shares)		1			7,666,667	7,666,667
Class B ordinary shares \| Sponsor
Shareholders' Deficit
Ordinary shares, shares issued (in shares)	1
Ordinary shares, shares outstanding (in shares)	1
Class B ordinary shares \| Director
Shareholders' Deficit
Conversion of Class B ordinary shares to Class A ordinary shares not subject to possible redemption (in shares)	120,000

Shareholders' Deficit - Warrant

Shareholders' Deficit - Warrants (Details) - $ / shares	9 Months Ended
Shareholders' Deficit - Warrants (Details) - $ / shares	Sep. 30, 2024	Dec. 31, 2023	Oct. 17, 2022
Shareholders' Deficit
Warrants outstanding	2,300,000	2,300,000
Class A ordinary shares
Shareholders' Deficit
Share Price	$ 9.20
Redemption of warrants when the price per class A ordinary share equals or exceeds $18.00
Shareholders' Deficit
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants	20 days
Redemption period	30 days
Stock price trigger for redemption of public warrants	$ 18
Warrants
Shareholders' Deficit
Exercise price of warrant	$ 11.50
Private Placement Warrants
Shareholders' Deficit
Warrants outstanding	13,350,000	13,350,000
Exercise price of warrant			$ 11.50
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Public Warrants
Shareholders' Deficit
Warrants outstanding	11,500,000	11,500,000
Fractional warrants issued upon conversion of units	0
Warrants exercisable term from the completion of business combination	30 days
Warrants exercisable term from closing of initial public offering	12 months
Maximum period after business combination in which to file registration statement	20 days
Public Warrants expiration term	5 years
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	115%

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	3 Months Ended		9 Months Ended
Fair Value Measurements (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Assets:
Cash and Investments held in Trust Account - U.S. Treasury Securities	$ 166,325,780		$ 166,325,780		$ 249,254,022
Fair value assets level 1 to level 2 transfers amount 1	0	$ 0	0	$ 0
Fair value assets level 2 to level 1 transfers amount 1	0	0	0	0
Fair value assets transferred into (out of) level 3	0	$ 0	0	$ 0
Level 1 \| US Treasury Securities \| Recurring
Assets:
Cash and Investments held in Trust Account - U.S. Treasury Securities	$ 166,325,780		$ 166,325,780		$ 249,254,022

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

1 Months Ended

9 Months Ended

Nov. 13, 2024

Oct. 18, 2024

Oct. 02, 2024

Jan. 10, 2024

Jan. 26, 2021

Feb. 28, 2021

Sep. 30, 2024

Nov. 12, 2024

Nov. 11, 2024

Nov. 08, 2024

Oct. 25, 2024

Oct. 24, 2024

Jan. 25, 2024

Dec. 31, 2023

Mar. 18, 2022

Subsequent event

Deferred underwriting commissions

$ 8,000,000

Unsecured promissory note | Sponsor

Subsequent event

Monthly contribution to trust account

$ 150,000

Class A ordinary shares

Subsequent event

Common shares, shares outstanding (in shares)

22,304,432

Class A ordinary shares | Sponsor

Subsequent event

Common shares, shares outstanding (in shares)

7,546,666

Class A ordinary shares subject to possible redemption

Subsequent event

Ordinary shares subject to possible redemption, shares outstanding (in shares)

14,637,766

23,000,000

Ordinary shares subject to possible redemption, par value (in dollars per share)

$ 0.0001

Class B Ordinary Shares

Subsequent event

Common shares, shares outstanding (in shares)

7,666,667

Class B Ordinary Shares | Sponsor

Subsequent event

Common shares, shares outstanding (in shares)

Class B Ordinary Shares | Founder shares | Sponsor

Subsequent event

Sale of Units, net of underwriting discounts (in shares)

5,750,000

40,000

Subsequent events

Subsequent event

Deferred underwriting commissions

$ 2,800,000

Trust Account

$ 25,135,029

Subsequent events | Unsecured promissory note | Sponsor

Subsequent event

Monthly contribution to trust account

$ 150,000

Subsequent events | Class A ordinary shares

Subsequent event

Common shares, shares outstanding (in shares)

9,880,095

Subsequent events | Class A ordinary shares | Unsecured promissory note | Sponsor

Subsequent event

Monthly contribution to trust accounts per shares

$ 0.02

Subsequent events | Class A ordinary shares | Common Stock

Subsequent event

Ordinary shares exercised

12,424,337

Ordinary shares for cash at a redemption price

$ 11.43

Aggregate redemption amount

$ 142,010,171

Subsequent events | Class A ordinary shares subject to possible redemption

Subsequent event

Ordinary shares subject to possible redemption, shares outstanding (in shares)

2,075,000

Ordinary shares subject to possible redemption, par value (in dollars per share)

$ 0.0001

Subsequent events | Class B Ordinary Shares | Founder shares

Subsequent event

Common stock, reserved for issuance upon consummation of business combination (in shares)

691,666